PULMONX CORPORATION Interest Expense Nonoperating
PULMONX CORPORATION (LUNG) reported Interest Expense Nonoperating of $1.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-04
- PULMONX CORPORATION interest expense nonoperating for the quarter ending 2026-06-30 was $1.22M, a 52.44% increase year-over-year.
- PULMONX CORPORATION interest expense nonoperating for the quarter ending 2026-03-31 was $976.00K, a 24.97% increase year-over-year.
- PULMONX CORPORATION interest expense nonoperating for the quarter ending 2025-12-31 was $770.00K, a 8.55% decline year-over-year.
- PULMONX CORPORATION interest expense nonoperating for the quarter ending 2025-09-30 was $805.00K, a 9.65% decline year-over-year.
- PULMONX CORPORATION interest expense nonoperating for fiscal 2025 was $3.15M, a 10.04% decline from fiscal 2024.
- PULMONX CORPORATION interest expense nonoperating for fiscal 2024 was $3.51M, a 8.51% increase from fiscal 2023.
- PULMONX CORPORATION interest expense nonoperating for fiscal 2023 was $3.23M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.22M 10-Q · filed 2026-08-04 | $2.19M 10-Q · filed 2026-08-04 | $2.96M derived: sum of 3 quarters · filed 2026-08-04 | $3.77M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $976.00K 10-Q · filed 2026-05-04 | $1.75M derived: sum of 2 quarters · filed 2026-05-04 | $2.55M derived: sum of 3 quarters · filed 2026-05-04 | $3.35M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $770.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.57M derived: sum of 2 quarters · filed 2026-03-10 | $2.37M derived: sum of 3 quarters · filed 2026-08-04 | $3.15M 10-K · filed 2026-03-10 |
| 2025-09-30 | $805.00K 10-Q · filed 2025-11-12 | $1.60M derived: sum of 2 quarters · filed 2026-08-04 | $2.38M 10-Q · filed 2025-11-12 | $3.23M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $799.00K 10-Q · filed 2026-08-04 | $1.58M 10-Q · filed 2026-08-04 | $2.42M derived: sum of 3 quarters · filed 2026-08-04 | $3.31M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $781.00K 10-Q · filed 2026-05-04 | $1.62M derived: sum of 2 quarters · filed 2026-05-04 | $2.51M derived: sum of 3 quarters · filed 2026-05-04 | $3.40M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $842.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.73M derived: sum of 2 quarters · filed 2026-03-10 | $2.62M derived: sum of 3 quarters · filed 2026-03-10 | $3.51M 10-K · filed 2026-03-10 |
| 2024-09-30 | $891.00K 10-Q · filed 2025-11-12 | $1.78M derived: sum of 2 quarters · filed 2025-11-12 | $2.67M 10-Q · filed 2025-11-12 | $3.57M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $891.00K 10-Q · filed 2025-08-01 | $1.77M 10-Q · filed 2025-08-01 | $2.68M derived: sum of 3 quarters · filed 2025-08-01 | $3.57M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $883.00K 10-Q · filed 2025-05-02 | $1.79M derived: sum of 2 quarters · filed 2025-05-02 | $2.68M derived: sum of 3 quarters · filed 2025-05-02 | $3.54M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $905.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.80M derived: sum of 2 quarters · filed 2025-02-25 | $2.66M derived: sum of 3 quarters · filed 2025-02-25 | $3.23M 10-K · filed 2025-02-25 |
| 2023-09-30 | $893.00K 10-Q · filed 2024-11-01 | $1.76M derived: sum of 2 quarters · filed 2024-11-01 | $2.33M 10-Q · filed 2024-11-01 | |
| 2023-06-30 | $864.00K 10-Q · filed 2024-08-02 | $1.44M 10-Q · filed 2024-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |